[go: up one dir, main page]

MX2016012319A - Formulaciones antihelminticas veterinarias estables. - Google Patents

Formulaciones antihelminticas veterinarias estables.

Info

Publication number
MX2016012319A
MX2016012319A MX2016012319A MX2016012319A MX2016012319A MX 2016012319 A MX2016012319 A MX 2016012319A MX 2016012319 A MX2016012319 A MX 2016012319A MX 2016012319 A MX2016012319 A MX 2016012319A MX 2016012319 A MX2016012319 A MX 2016012319A
Authority
MX
Mexico
Prior art keywords
anthelmintic
methods
stable veterinary
veterinary formulations
stable
Prior art date
Application number
MX2016012319A
Other languages
English (en)
Other versions
MX389554B (es
Inventor
Yeritsyan Karen
Original Assignee
Donaghys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donaghys Ltd filed Critical Donaghys Ltd
Publication of MX2016012319A publication Critical patent/MX2016012319A/es
Publication of MX389554B publication Critical patent/MX389554B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Toxicology (AREA)

Abstract

Se describen en la presente formulaciones veterinarias estables y los métodos de tratamiento y uso, que comprenden al menos una lactona macrocíclica y levamisol como agentes antihelmínticos activos, opcionalmente también con al menos un antihelmíntico de la clase bencimidazol, en donde los ingredientes activos se disuelven juntos en un sistema de solventes que comprende dimetilsulfóxido (DMSO). Las formulaciones veterinarias, métodos y uso de las mismas incluyen la capacidad de suministrar dos o más activos antihelmínticos en la única solución (o suspensión) mientras que también mantengan la estabilidad de la formulación cuando se almacenan durante un período de tiempo. El suministro de diferentes antihelmínticos con diferentes actividades permite que se dirijan a diversas clases de parásitos en una sola dosis.
MX2016012319A 2014-03-24 2015-03-24 Formulaciones antihelminticas veterinarias estables. MX389554B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ622869A NZ622869A (en) 2014-03-24 2014-03-24 Stable veterinary anthelmintic formulations
PCT/NZ2015/000018 WO2015147655A1 (en) 2014-03-24 2015-03-24 Stable veterinary anthelmintic formulations

Publications (2)

Publication Number Publication Date
MX2016012319A true MX2016012319A (es) 2017-01-06
MX389554B MX389554B (es) 2025-03-20

Family

ID=52464905

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012319A MX389554B (es) 2014-03-24 2015-03-24 Formulaciones antihelminticas veterinarias estables.

Country Status (11)

Country Link
US (1) US10449179B2 (es)
EP (1) EP3122352A4 (es)
CN (1) CN106132409B (es)
AR (1) AR099829A1 (es)
AU (3) AU2015237371A1 (es)
CA (1) CA2942008C (es)
MX (1) MX389554B (es)
NZ (2) NZ622869A (es)
RU (1) RU2711200C2 (es)
UY (1) UY36045A (es)
WO (1) WO2015147655A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018038623A1 (en) * 2016-08-23 2018-03-01 Donaghys Limited Improvements in parasite treatments
EA201992125A1 (ru) 2017-03-17 2020-03-16 КРКА, д.д., НОВО МЕСТО Стабильная ветеринарная композиция для местного применения
EP3829664A4 (en) 2018-08-03 2022-05-04 Nectero Medical, Inc. PURIFIED PENTAGALLOYGLUCOSE AND DELIVERY DEVICES
JP7199653B2 (ja) * 2018-08-17 2023-01-06 住化エンバイロメンタルサイエンス株式会社 樹脂製容器入り外部寄生虫駆除剤
WO2020198371A1 (en) * 2019-03-26 2020-10-01 Nectero Medical, Inc. Methods and devices for treatment of post-surgery laxity of tendons and tendon repair
CN111840234A (zh) * 2020-08-14 2020-10-30 瑞普（天津）生物药业有限公司 一种兽用复方驱虫颗粒剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327761D0 (en) * 1983-10-17 1983-11-16 Janssen Pharmaceutica Nv Parasiticidal formulations
NZ248486A (en) 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
DE19654079A1 (de) * 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
NZ508969A (en) 1999-06-04 2002-12-20 Nufarm Ltd Pesticidal emulsion containing levamisole in the aqueous phase and a macrocyclic lactone anthelmintic in the organic phase
NZ515772A (en) 1999-06-04 2002-12-20 Nufarm Ltd Pesticidal emulsion composition containing levamisole in the aqueous phase and an anthelmintic in the organic phase
LT1610613T (lt) 2003-04-04 2017-03-27 Merial, Inc. Vietinio taikymo antihelmintinės veterinarinės kompozicijos
NZ535644A (en) 2003-07-25 2007-05-31 Ashmont Holdings Ltd Anthelmintic formulations
KR101233488B1 (ko) 2005-09-15 2013-02-14 메리얼 리미티드 구충 제형
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
RU2367435C1 (ru) * 2008-03-26 2009-09-20 Александр Анатольевич Смирнов Состав для лечения гельминтозов домашних животных
AR081970A1 (es) 2010-06-24 2012-10-31 Intervet Int Bv Formulacion inyectable de una lactona macrociclica y levamisol, formulacion y uso veterinario
NZ594610A (en) * 2011-08-16 2013-03-28 Virbac New Zealand Ltd Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants
WO2013043064A1 (en) * 2011-09-23 2013-03-28 Alleva Animal Health Limited Veterinary anthelmintic delivery system

Also Published As

Publication number Publication date
RU2711200C2 (ru) 2020-01-15
EP3122352A1 (en) 2017-02-01
MX389554B (es) 2025-03-20
AU2022252717A1 (en) 2022-11-03
CN106132409B (zh) 2020-09-01
EP3122352A4 (en) 2017-11-01
CA2942008C (en) 2022-06-21
AR099829A1 (es) 2016-08-24
AU2015237371A1 (en) 2016-09-15
RU2016140272A (ru) 2018-04-24
RU2016140272A3 (es) 2018-09-26
NZ701697A (en) 2016-05-27
CN106132409A (zh) 2016-11-16
US10449179B2 (en) 2019-10-22
CA2942008A1 (en) 2015-10-01
AU2022252717B2 (en) 2024-09-05
NZ622869A (en) 2015-01-30
WO2015147655A1 (en) 2015-10-01
UY36045A (es) 2015-07-31
US20170007584A1 (en) 2017-01-12
AU2020227063A1 (en) 2020-09-24

Similar Documents

Publication Publication Date Title
CL2018003681A1 (es) Derivados de ácido borónico y usos terapéuticos de los mismos
MX2016012319A (es) Formulaciones antihelminticas veterinarias estables.
AR133768A2 (es) Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
CL2020000739A1 (es) Agente prolongado de control de ectoparasito para animales.
CO2019007888A2 (es) Inhibidores selectivos de jak1
UY37435A (es) Pirrolidinas sustituidas y métodos para usarlas
CO2017010065A2 (es) Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina
AR104984A1 (es) Compuestos selectivos para pyy y sus usos
MX2015012559A (es) Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson.
MX381819B (es) Derivados de heterociclico opcionalmente condensados de pirimidina útiles para el tratamiento de enfermedades inflamatorias, metabólicas oncológicas y autoinmunitarias.
NI201500163A (es) Composiciones, métodos y sistemas para el suministro por vía respiratoria de tres o más agentes activos.
UY36761A (es) Formulación oral sólida que contiene irinotecán y método 20 de preparación de la misma
CR20170003A (es) Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble
MX2021009377A (es) Formulaciones de espuma y aparatos para su suministro.
MX2018004664A (es) Antagonistas de ep4.
CO2017006958A2 (es) Formulaciones farmacéuticas que comprenden cangrelor de alta pureza y métodos para la preparación y uso de los mismos
MX2018004304A (es) DERIVADOS DE QUINOXALINA Y PIRIDOPRAZINA COMO INHIBIDORES DE PI3Kß.
CO2018001359A2 (es) Derivados del ácido 5-(n-bencil-tetrahidroisoquinolin-6-il)-piridin-3-il acético como inhibidores de la replicación del virus de la inmunodeficiencia humana
UY37555A (es) Derivados de ácido piridin-3-il-acético como inhibidores de la replicación del virus de la inmunodeficiencia humana
MX375485B (es) Derivados biciclicos de piridina, pirazina y pirimidina como inhibidores de pi3k beta
AR100850A1 (es) Composición farmacéutica que comprende desmopresina y un agente estabilizador
AR100815A1 (es) Formulaciones parasiticidas transdérmicas, método, uso
BR112017009852A2 (pt) composto, composição, e, usos de um composto
CU20100172A7 (es) Derivados heterocíclicos de urea y métodos de uso de los mismos-211
CU20100237A7 (es) Derivados heterocíclicos de la urea y sus métodos de empleo